Loading stock data…
SBRA
$20.36-0.30 (-1.45%)
Market ClosedLast close May 1
Sabra Health Care REIT, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Sabra Health Care REIT, Inc. in the Real Estate sector is trading at $20.36. The stock is currently near its 52-week high of $21.07, remaining 8.5% above its 200-day moving average. Technical signals show neutral RSI of 52 and bullish MACD crossover, explaining why SBRA maintains its current momentum and trend strength. The Whystock Score of 75/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Neutral momentum (RSI 52) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$20.36
Potential Downside
38.2%
Whystock Fair Value$12.59
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus13 analysts
Buy
Mean target$22.00+8.1%
Range$20.00 – $24.00
Fundamentals
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Hea...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$5.04B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
31.21
Beta
Defensive asset. Lower volatility than the S&P 500.
0.65
Div Yield
Strong income play. Yield provides a meaningful total return floor.
613.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
6.46%
Volume
Today's trading volume
2.21M
Recent News
Sabra Health Care REIT Inc (SBRA) Q1 2026 Earnings Call Highlights: Strong Growth in Senior ...
Sabra Health Care REIT Inc (SBRA) reports a robust first quarter with significant increases in FFO and AFFO, while advancing AI-driven operational efficiencies.
Sabra Healthcare REIT Q1 Earnings Call Highlights
Sabra Healthcare REIT (NASDAQ:SBRA) executives highlighted accelerating investment activity, improving operating metrics across key portfolios, and a stable reimbursement and regulatory backdrop during the company’s first-quarter 2026 earnings call. Management also reaffirmed full-year 2026 guidance
Sabra (SBRA) Q1 2026 Earnings Transcript
Before we begin, I want to remind you that we will be making forward-looking statements in our comments and in response to your questions concerning our expectations regarding our future financial position and results of operations, including our earnings guidance for 2026, our expectations regarding our tenants and operators, and our expectations regarding our acquisition, disposition, and investment plan. SHOP occupancy dipped slightly overall, but it was all in Canada, which had very strong year-over-year growth and currently sits at 93.4%, so almost effectively full, and there will probably be ups and downs a little bit with that portfolio.
Sabra Health Care REIT, Inc. Q1 2026 Earnings Call Summary
Moby summary of Sabra Health Care REIT, Inc.'s Q1 2026 earnings call
Sabra Healthcare (SBRA) Tops Q1 FFO and Revenue Estimates
Sabra (SBRA) delivered FFO and revenue surprises of +2.63% and +8.02%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?